Lifecycle firm: Covington & Burling




Life Science Stars

REGULATORY

Ellen J Flannery, Washington, DC
Peter Barton Hutt, Washington, DC
Richard F Kingham, Washington, DC & London
Demetrios L Kouzoukas, Washington, DC
Anna D. Kraus, Washington, DC
Michael S Labson, Washington, DC
Gerald F Masoudi, Washington, DC
Peter O Safir, Washington, DC

INTELLECTUAL PROPERTY

Jeffrey B Elikan, Washington DC
George F Pappas, Washington DC
Andrea Reister, Washington DC

FINANCE & TRANSACTIONAL

Edward C Britton, Washington, DC
Ellen B Corenswet, New York
Catherine J Dargan, Washington, DC
Bruce Deming, San Francisco
Edward H Dixon, Washington, DC
John A Hurvitz, Washington, DC
Emily I Leonard, Redwood Shores
Amy L Toro, San Francisco
James C Snipes, San Francisco

NON-IP LITIGATION AND ENFORCEMENT

Patrick S Davies, Washington, DC
James R Dean, Washington, DC
Timothy C Hester, Washington, DC
Ethan M Posner, Washington, DC
Peter O Safir, Washington, DC
Robert C. “Mike” Brock, Washington, DC
Mark H Lynch, Washington, DC

With Life Science Stars in all four categories, Covington & Burling possesses one of the most balanced and dedicated life sciences practice groups in the legal market. "Covington is definitely one of our top go-to firms," explains one client, who regularly uses the firm's full catalogue of legal services. "It is a firm you can go to that has the capacity to handle so many kinds of issues."

Having interviewed a number of its stars, it was easy to see how passionate lawyers in the practice group were about assisting the industry. Their dedicated team understands the industry and can untangle the most complicated legal problems in a seamless, focused manner. "Covington ranks up there in terms of quality of advice and responsiveness," says another client.

Having a premiere FDA practice, a trait only a handful of competitors share, distinguishes Covington's team from the market at large. Richard Kingham and Peter Safir, to name a few, lead one of the firm's most important assets. It is truly an important piece of the practice group and complements a number of other areas. It is valued greatly by clients using the firm to handle a multitude of other legal matters.

"You can call up the best transactional lawyers in America, but if you are doing a pharmaceutical license, there is so much regulatory expertise and IP expertise that is needed," a client explains. "Covington provides that expertise in a seamless way. When we work with them, I don't think there is anyone better. They were terrific."

Covington's breadth of practice area offerings is absolutely first rate. They have one of the strongest transactional benches, led by John Hurvitz in Washington, DC and James Snipes in San Francisco. George Pappas, an intellectual property partner with over 36 years of experience, has acted as lead counsel in more than 350 cases. Tim Hester, chair of the firm's Management and Executive Committee, is trusted by clients and admired by peers for antitrust matters. The team delivers star power at every stage of a product's life cycle.

"It is a different sort of firm – at Covington they really understand the industry and the challenges we face," explains a client, raving about the full service capabilities of the firm. "When you work with their transactional attorneys they bring an IP perspective and a regulatory perspective."

Clients were also eager to point out other characteristics of the firm beyond their legal know-how and capacity. "One reason I am always happy to use Covington in addition to the excellent support they give to us, [is that] Covington has a very diverse team," explains another client, who ranked diversity as an important issue when hiring outside counsel. The client also mentioned that, "they have been very willing to use alternative fee arrangements."

Practice group breakdown of Life Science Stars




More from the Managing IP blog


June 2013

The Madrid Protocol comes of age

India’s accession means the Madrid Protocol now covers more than two-thirds of the world’s population. Is this the tipping-point for the international trade mark system, and what reforms are needed? Emma Barraclough, James Nurton and Alli Pyrah report



Most read articles

Poll

Following the US Apple v Samsung trial, do you think juries should play a role in patent cases?







Supplements